Can cell and gene therapies be programmed with sophisticated behaviors, to sense, make decisions, and treat important diseases effectively? Synthetic gene circuits may hold the key.
- Assessing Quality Of Viral Vectored Vaccines
- India’s New Drugs, Medical Devices, And Cosmetics Draft Bill 2022
- The Future Of Gene Therapy Depends On New Delivery Vehicles
- Cost-Effective Biomanufacturing Of Lentiviral Vectors
- Move Beyond Strength To Motivation
- "Lean On Me": Defining Risk-Sharing In Cell & Gene Therapy Manufacturing Partnerships
- CDMO Selection In Our Post-COVID World
- Jump-Start Your Next CDMO Outsourcing Project With This Checklist
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
Selecting A Reversed-Phase Column For The Peptide Mapping Analysis Of A Biotherapeutic Protein
In this study we review reversed-phase (RP) column selection considerations for peptide mapping applied to the routine characterization and analysis of biotherapeutic proteins.
Combining VIPS And ATUM To Accelerate Cell Line Manufacturing
Scientists are constantly striving to develop the highest producing clones and to do it faster. We now demonstrate how this can be achieved by using only a handful of cloning plates.
How To Develop A Cell Therapy Manufacturing Roadmap
A good manufacturing roadmap provides flexible guidelines to advance automation. It’s a living document and will be refined many times as manufacturing needs and processes evolve. The key is mapping out the entire process and developing a clear understanding of what needs to be done and when. Here are the key questions to ask when building a manufacturing roadmap.
Closed Manufacturing System For Autologous Cell Therapy Production
Complete manufacturing system delivered technology innovation, novel automation solutions, and substantial IP in the cell therapy manufacturing automation domain.
5 Advantages Of A Single-Use Manifold Configurator
The interface between systems and bags or bottles often proves a bottleneck. Learn how to adapt single-use filling assemblies to meet changing needs in the production and filling process.
High Efficiency Single Cell Cloning Of iPSCs Using Combination Of MatriClone And VIPS
Review an effective turnkey solution for generating significantly more viable iPSC clones per plate along with image documentation for their clonal derivation.
How to Select the Right Integrity Test Instrument
Filter integrity testing, from its origins in the 1970s, has undergone significant changes over the last 40 years as industry needs, and the evolution of regulatory expectations have pushed boundaries to reduce risk and increase patient safety. This guide will help you select the right integrity test instrument, including criteria that will allow accurate filter integrity testing that is fully compliant to current regulations.
Do I Need To Validate? How To Make An Informed Decision In 4 Steps
Nobody ever said software validation is easy. Validation is twice as tough if you are plagued by uncertainty and asking yourself: do I really need to validate? It’s a legitimate question. In this paper we walk you through the necessary thought process to make an informed decision.
Differentiation Of Leucine And Isoleucine Using Electron Activated Dissociation (EAD)
We demonstrate the combination of routine characterization and elucidation of challenging residues in one single analysis, without the need for sample specific optimization.
Integrated Manufacturing: Chromatography Meets Predesigned DeltaV
Cytiva’s pre-defined automation solution, Figurate, is now available as a turnkey solution by combining our industry-leading ÄKTA process chromatography system with the reliability of the DeltaV DCS platform.
CELL AND GENE LIVE
To achieve commercial success, a developed process must be scalable and suitable for a manufacturing environment. The scaling strategy depends on the type of cell therapy. Check out our latest Cell & Gene Live - now available On-Demand.Cell & Gene Live Archive
CELL AND GENE CONTENT COLLECTIONS
While both allogeneic and autologous therapies use similar technologies common to the growth of cells, the scale is different. In this e-book from Cell & Gene, we've curated insightful editorial that concentrates on the advancements of both allogeneic and autologous therapies and how to manufacture them at scale.More Content Collections